Compounded GLP-1 Drugs Raise Safety Concerns
Compounded versions of GLP-1 drugs, including cheaper alternatives to Ozempic, are raising concerns among doctors and the FDA due to serious safety risks. While more accessible and affordable than brand-name medications, these compounded drugs lack equivalent regulatory oversight.